University of Leicester researchers have developed ONCO-ACS, an AI-powered model to predict mortality, bleeding, and ischaemic events in cancer patients after heart attacks.
Key Details
- 1ONCO-ACS is an AI model combining cancer-related and standard clinical data to predict death, bleeding, or cardiovascular events within six months post-heart attack.
- 2The study analyzed data from over 1 million heart attack patients, including more than 47,000 with cancer, from England, Sweden, and Switzerland.
- 3Results showed nearly one in three cancer patients died within six months, one in 14 suffered major bleeding, and one in six had another cardiovascular event.
- 4The model is published in The Lancet and funded by Cancer Research UK and the British Heart Foundation.
- 5The tool aims to guide personalized treatment decisions and design future trials for this complex patient group.
Why It Matters
This model addresses a significant clinical gap by offering tailored risk assessment for cancer patients post-heart attack, a group with limited guidance so far. Its real-world data approach and integration potential could improve patient outcomes and inform more precise treatment strategies.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.